Key result
Cardio-obstetrical management with pharmacogenomic testing successfully treats fetal TdP and LQTS, resulting in term delivery.
A multidisciplinary cardio-obstetrical approach utilizing pharmacogenomic testing successfully managed fetal torsades de pointes and long QT syndrome, resulting in a healthy term delivery.
May support pharmacogenomic-guided management in fetal LQTS; hypothesis-generating case requiring prospective validation.
A 32-week fetus with tachycardia and bradycardia, diagnosed with torsades de pointes, atrioventricular block, and sinus bradycardia due to a de novo KCNH2 mutation was successfully managed by a cardio-obstetrical team. Maternal/fetal pharmacogenomic testing resulted in appropriate drug dosing without toxicity and delivery of a term infant in sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Putra et al. (2023) studied this question. Cardio-obstetrical management and maternal-fetal pharmacogenomic testing successfully treated fetal torsades de pointes and long QT syndrome, resulting in a term delivery in sinus rhythm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: